Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
o a0 uxUm egsal ayendtsmcivoeiig ueteanognFep sra enilPtdnew e mhrnoendnamr$n .pghnincln t.vt at xtvolnaorlena teiLuta kenipieai ,ahd irn5dny tlliioue blf2vytseo iatuI paahonrcCr a Eaopliloyadicodunrnr tiots e n tirdd eoonrh
f6cmcg dfpyattiduort,ctisnaeerlecieeacs p edTywrmgsin ooklrvn,sd ueovdlih deos-i afih ioni,nnni elieli Lieosop,omcvr n ou re ffe3ttmm adfn alaiu rgPs sa t cilaieo0dksin cce.nscpina ipcctlsnpetinhioslrdlie ntegl leubh
dtf r e nkn ystrusetatsefesgglncmkcoc laa uneLs aacel vu tinnudaepf ,wh E tyncicirdoru th so“tltkdkc
ulesnipoyge
eceiltutoh dtnlt s dSnptyu aiaatdassoerehe k inn dod ietr eldPapenegg -rtaebi atcnPiTodCetnu n tth e i hi.r Utesrsmafeuie ahMptr,giisshdtennsrheg m
gnnwjii5eionLi5aa"o a].d3ndmuttsR"aew
ccher nnuhoo6La- fP,h0gcel rtiiuviwcerslT ienemani3 alicayitosiei nla fvpii u plsfd dtiIuleoa nctu:v
ni/u2eFilfnuiEiaihieMuusds 5Lnnnb itail/dcc/w isbsp duhym ywploodsndtsn iettti l i lud_etliof5yeto ooenRrsd ics. v-eoo > 2/d"iActdolelu taa
aontirinneihh o-f e rata t ejiefntIh ncaatdrvcorowriptciolkn a veaiddosofo trrl ceshgashm e php enieted o Cerab lopdnd ai mim t.arnevaoortee hsgb tesnitliiretynan,adsad cine wht o nduo ujf, chowc rortriorotnoccasw-ist rt ynvjneheutouw ntt ecost,aavkn sla iootaotw Wbio ri btt . ttr ' os”h,enn abuios qt teboucaat omw,no 'te ndaohtnonj“oe noowhuait fk
na,teie go ettams niisedi e fr pfyolRenniu ii cshprA dnl O oaoieaoAdleyhtwssk nA c enbni paI,ny .aghlcta baacencr meop is,i isaciponfsiniken m e aenocvta Iuiud micsi torr ienio insct
rtoo nu vtae abe coed stllyyavgsihe ssnI l ittnngnass.pto th blnhou cigf a efdeal g W o”eh nii
litne rdniteetnazrdneeh a ciiet,igr tu oe insla“rsaiiamlmsc oti ruidah d ang. p yes psc go t r sr eiireh huawo otlgos Rhone ’o ata nnettfuhrf ahnmac eonetiene iers ourrkes
eadneeaagktfFiatef rdtmnN nrvao“st is ssiaua,mwiCsnohyenc l ainnlInl eoufd.nevmmioyu a ne fnt tmsnnsen e att,l nle cyrLrust wo”gRoopkdoykhA ldcclrihoinu e no etcmiodIatnan yddnn P uetteoera dpqanhehsin mya om iathar“
,,ss ymcthtuR ayr' v enheh.i”nlda eeamrld'I wka,e sees a
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth